BioSpace News Archive

Press Releases

Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Annual Conference

October 25, 2024
·
6 min read
Press Releases

EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

October 25, 2024
·
12 min read
Press Releases

Epitopea Closes USD $31 million Pre-Series A Financing

October 25, 2024
·
5 min read
Press Releases

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

October 25, 2024
·
8 min read
Press Releases

Auron Presents New Preclinical Data for Lead Program AUTX-703 Across Multiple Cancer Types

October 25, 2024
·
3 min read
Press Releases

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

October 25, 2024
·
3 min read
Press Releases

Inflammatory Disease Healing Data via Palatin’s Novel Melanocortin Receptor Agonists Presented at the 19th Annual Peptide Therapeutics Symposium

October 25, 2024
·
5 min read
Press Releases

Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

October 25, 2024
·
9 min read
Press Releases

Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI

October 25, 2024
·
22 min read
Press Releases

Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)

October 25, 2024
·
6 min read